Interestingly, we also observed ADAM17 expressing immune cells infiltrating bile duct epithelium in both PBC and PSC patients, a process that may further alter cholangiocyte function, signaling, and responses to cholestasis. Here, ADAM17 is linked to primary biliary cholangitis.